188 related articles for article (PubMed ID: 2213040)
21. Double-blind study of botulinum toxin in spasmodic torticollis.
Tsui JK; Eisen A; Stoessl AJ; Calne S; Calne DB
Lancet; 1986 Aug; 2(8501):245-7. PubMed ID: 2874278
[TBL] [Abstract][Full Text] [Related]
22. Change in pattern of muscle activity following botulinum toxin injections for torticollis.
Gelb DJ; Yoshimura DM; Olney RK; Lowenstein DH; Aminoff MJ
Ann Neurol; 1991 Apr; 29(4):370-6. PubMed ID: 1929208
[TBL] [Abstract][Full Text] [Related]
23. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
[TBL] [Abstract][Full Text] [Related]
24. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
26. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread.
Borodic GE; Joseph M; Fay L; Cozzolino D; Ferrante RJ
Head Neck; 1990; 12(5):392-9. PubMed ID: 2211099
[TBL] [Abstract][Full Text] [Related]
27. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
Poungvarin N; Viriyavejakul A
J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
[TBL] [Abstract][Full Text] [Related]
29. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Ford B; Louis ED; Greene P; Fahn S
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
[TBL] [Abstract][Full Text] [Related]
30. [Injection of botulinum toxin as a new treatment of torticollis].
Aquilonius SM; Cesarini KG; Stålberg E
Lakartidningen; 1990 Dec; 87(51-52):4408-10. PubMed ID: 2177127
[TBL] [Abstract][Full Text] [Related]
31. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
Kaufman DM
J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
[TBL] [Abstract][Full Text] [Related]
32. Psychological functioning before and after treatment of torticollis with botulinum toxin.
Jahanshahi M; Marsden CD
J Neurol Neurosurg Psychiatry; 1992 Mar; 55(3):229-31. PubMed ID: 1564490
[TBL] [Abstract][Full Text] [Related]
33. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.
Lange DJ; Rubin M; Greene PE; Kang UJ; Moskowitz CB; Brin MF; Lovelace RE; Fahn S
Muscle Nerve; 1991 Jul; 14(7):672-5. PubMed ID: 1922173
[TBL] [Abstract][Full Text] [Related]
34. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
35. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
36. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.
Poewe W; Deuschl G; Nebe A; Feifel E; Wissel J; Benecke R; Kessler KR; Ceballos-Baumann AO; Ohly A; Oertel W; Künig G
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):13-7. PubMed ID: 9436721
[TBL] [Abstract][Full Text] [Related]
37. A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.
Brefel-Courbon C; Simonetta-Moreau M; Moré C; Rascol O; Clanet M; Montastruc JL; Lapeyre-Mestre M
Clin Neuropharmacol; 2000; 23(4):203-7. PubMed ID: 11020124
[TBL] [Abstract][Full Text] [Related]
38. Low dose botulinum toxin in spasmodic torticollis.
D'Costa DF; Abbott RJ
J R Soc Med; 1991 Nov; 84(11):650-1. PubMed ID: 1744868
[TBL] [Abstract][Full Text] [Related]
39. Brachial plexopathy after Botulinum toxin administration for cervical dystonia.
Sampaio C; Castro-Caldas A; Sales-Luis MI; Alves M; Pinto L; Apolinario P
J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):220. PubMed ID: 8382272
[No Abstract] [Full Text] [Related]
40. Double-blind trial of botulinum toxin for treatment of focal hand dystonia.
Cole R; Hallett M; Cohen LG
Mov Disord; 1995 Jul; 10(4):466-71. PubMed ID: 7565828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
